News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘Melanoma’ clear

  • One of the shortcomings of a therapy that uses millions of identical antibodies to boost the immune system's attack on cancer cells is that many patients whose tumors recede in response to the treatment also experience serious inflammatory problems, such as severe diarrhea and rashes. In a new study, a team led by Dana-Farber Cancer Institute researchers shows that giving periodic infusions of such "monoclonal" antibodies to patients who have received a widely used cancer vaccine unleashes a strong immune response to tumors, with less-harsh side effects.

Tags: Melanoma, OvarianCancer, TargetedTherapy

  • Dana-Farber researchers are studying melanoma tumors' microenvironments to better understand how some melanoma continue to grow and survive despite the presence of anti-cancer drugs.

Tags: BasicResearch, Genomics, Melanoma

  • It's still possible to get too much sun exposure in winter. Dana-Farber's skin cancer specialists explain the dangers and offer sun safety tips to help you protect your skin while enjoying outdoor winter activities.

Tags: Melanoma, Prevention, SkinCancer

  • As the weather grows warmer, Dana-Farber Cancer Institute physicians and nurses are encouraging people to be aware of the dangers of overexposure to the sun and to practice sun safety

Tags: Melanoma, Prevention

  • Dana-Farber Cancer Institute researchers have developed a powerful method for charting the positions of key gene-regulating molecules called nucleosomes throughout the human genome.

Tags: Genomics, Melanoma

  • ABC News' Sam Donaldson shared his experience as a melanoma patient during his keynote speech at the Dana-Farber Cancer Institute Joint Visiting Committee Symposium dinner Nov. 15.

Tags: Melanoma

  • The discovery of a cancer gene that drives drug resistance in melanomas could lead to more effective drugs for melanoma and other cancers in the future.

Tags: Melanoma, Genetics

  • Dana-Farber and Broad Institute researchers have identified two mutations that collectively occur in 71 percent of malignant melanoma tumors. These highly "recurrent" mutations may be the most common mutations in melanoma cells found to date.

Tags: Genomics, Melanoma

  • In a demonstration that even some of the most hard-to-treat tumors may one day succumb to therapies aimed at molecular "weak points," researchers at Dana-Farber report the first instance in which metastatic melanoma has been driven into remission by a targeted therapy.

Tags: Melanoma, TargetedTherapy

  • A clinical trial for advanced melanoma caused growths to recede or stabilize in half of the participants by blocking a protein interaction that prevents T cells from attacking cancerous cells, reports lead author Stephen Hodi, MD.

Tags: ImmuneSystem, Melanoma

Showing 1-10 of 21 items